相关实验视频

Updated: Jun 12, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

心脏衰竭的心脏再同步治疗基于斯特劳斯标准的左捆分支块

Athanasios Saplaouras¹, Konstantinos Vlachos¹, Panagiotis Mililis¹

¹Arrhythmia Unit, Onassis Cardiac Surgery Center, Athens, Greece.

ESC heart failure

|September 20, 2024

概括

更严格的斯特劳斯标准左捆分支阻断 (St-LBBB) 改善心脏再同步治疗 (CRT) 响应心力衰竭患者. St-LBBB确定了非缺血性心肌病患者,他们从CRT中受益最多,减少住院治疗和死亡率.

科学领域:

心脏病学心脏病学
电子生理学电子生理学
心脏衰竭管理的管理

背景情况:

左捆枝块 (LBBB) 预测了对心脏再同步治疗 (CRT) 的反应.
很大一部分患者没有从CRT中受益.
对于LBBB (St-LBBB) 的更严格标准在预测CRT结果中的诊断实用性需要进一步研究.

研究的目的:

评估St-LBBB标准对CRT响应的影响.
评估St-LBBB对心力衰竭住院,心室节律失常 (VA) 事件和接受CRT的患者死亡率的影响.

主要方法:

对从接受CRT植入的LBBB心力衰竭患者前性收集数据的回顾性分析.
患者被分为St-LBBB和非St-LBBB组.
包括CRT反应,住院,VA事件和死亡率在内的结果在各组之间进行了比较.

主要成果:

符合St-LBBB标准的患者表现出显著更高的CRT反应率 (P < 0.01).
在非缺血性心肌病 (NICM) 和St-LBBB患者中观察到最大的益处,显示心力衰竭住院减少 (P < 0.0001),VA事件 (P < 0.001) 和死亡率 (P < 0.0001).
在St-LBBB中,在NICM患者中发现了一个VA发病率明显较低的子组 (P = 0.049).

结论:

根据St-LBBB标准,患者可以更好地选择CRT,特别是那些患有NICM的患者.
St-LBBB分类与CRT反应改善,住院减少,VA事件减少和死亡率降低有关.
需要进一步的研究,以充分阐明St-LBBB在优化CRT结果中的作用.

关键词:

在CRT响应时,CRT响应.施特劳斯 LBBBB LBBB 这是一个缺血性心肌病症缺血性心肌病症非缺血性心肌病变异性腹腔心律失常症腹腔心律失常症

更多相关视频

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

相关概念视频

Heart Failure Drugs: β-Blockers

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...

Disturbances in Heart Rhythm

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...